Differential Discussions

Guest Series: Have We Cured Hemophilia? Part 1

28 min · 4. juni 2025
episode Guest Series: Have We Cured Hemophilia? Part 1 cover

Description

Malissa & Dave are joined by George Fritsma. George Fritsma manages www.fritsmafactor.com [http://www.fritsmafactor.com], The Fritsma Factor, Your Interactive Hemostasis Resource for Precision BioLogic Inc., Dartmouth, NS; and “Coag Conversations” for BioMedica Diagnostics, Inc., Windsor, NS. If you want to learn more about George, please view this author interview: https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma [https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma]

Comments

0

Be the first to comment

Sign up now and become a member of the Differential Discussions community!

Get Started

2 months for 19 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

32 episodes

episode Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy artwork

Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy

Malissa & Dave are joined by David McGlasson to talk about chromogenic factor X assays and their use monitoring patients on warfarin. David McGlasson was a GS-13 staff researcher at the 59th Clinical Research Division at Lackland JBSA in Sant Antonio, TX until retirement. He holds degrees from the University of Incarnate Word and San Antonio College in San Antonio, TX and certification from the Gradwohl Schoolf of Laboratory Technique in Medical Technology. To read more about David, you can visit the Diapharma website https://diapharma.com/clot-club-david-mcglasson/ [https://diapharma.com/clot-club-david-mcglasson/] Here is the link to the article about chromogenic factor X assays: https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/ [https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/]

1. apr. 202544 min